Live Breaking News & Updates on Asco 2023

Stay updated with breaking news from Asco 2023. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Efficacy of Imetelstat in Achieving Red Blood Cell Transfusion Independence (RBC-TI) across Different Risk Subgroups in Patients with Lower-Risk Myelodysplastic Syndromes (LR-MDS) Relapsed/Refractory (R/R) to Erythropoiesis-Stimulating Agents (ESAs) in IMerge Phase 3 Study

Amer Zeidan, MBBS, MHS, presents data from the IMerge phase 3 study on the efficacy of imetelstat in achieving red blood cell transfusion independence across different risk subgroups in patients with lower-risk myelodysplastic syndromes relapsed/refractory to erythropoiesis-stimulating agents. ....

San Diego , United States , Samer Zeidan , International Prognostic Scoring System , Achieving Red Blood Cell Transfusion Independence , Different Risk Subgroups , Lower Risk Myelodysplastic Syndromes , Erythropoiesis Stimulating Agents , Partnership With , Myelodysplastic Syndrome , Imerge Study , Imerge Trial , Imerge Phase 3 Study , Lower Risk Mds , Lower Risk Myelodysplastic Syndrome , Red Blood Cell Transfusion Independence , Asco 2023 , Imetelstat Efficacy ,

Acute Lymphoblastic Leukemia: Trial Data From the ASCO and EHA 2023 Annual Meetings

Shared insight from key opinion leaders on clinical trial data in acute lymphoblastic leukemia from the ASCO 2023 and EHA 2023 Annual Meetings. ....

Lymphoblastic Leukemia , Trial Data From , Asco 2023 , Eha 2023 , American Society Of Clinical Oncology , European Hematology Association , Asco 2023 Annual Meeting , Eha 2023 Congress , Acute Lymphoblastic Leukemia , Chronic Myeloid Leukemia , Acute Myeloid Leukemia ,

Acute Myeloid Leukemia: Trial Data From the ASCO and EHA 2023 Annual Meetings

Following the ASCO 2023 and EHA 2023 Annual Meetings, experts discuss important updates in acute myeloid leukemia. ....

Myeloid Leukemia , Trial Data From , Asco 2023 , Eha 2023 , American Society Of Clinical Oncology , European Hematology Association , Asco 2023 Annual Meeting , Eha 2023 Congress , Acute Lymphoblastic Leukemia , Chronic Myeloid Leukemia , Acute Myeloid Leukemia ,

CAR T-Cell Therapy in Metastatic CRPC and Future Directions in Care

Closing out their final module, expert panelists consider the role of CAR T-cell therapy in metastatic castration-resistant prostate cancer and look toward future evolutions in the broader treatment landscape. ....

Treatment Approaches , Prostate Cancer , Cell Therapy , Future Directions , Metastatic Prostate Cancer , Castration Resistant Prostate Cancer , Cart Therapy , Cart Cell Therapyt Bispecifics , Bispecific Therapy , Clinical Trials , Asco 2023 , Asco Annual Meeting ,

Ongoing Clinical Trials in the Metastatic CRPC Setting

Key opinion leaders in metastatic castration-resistant prostate cancer share insight to key ongoing clinical trials within the landscape. ....

Treatment Approaches , Prostate Cancer , Clinical Trials , Metastatic Prostate Cancer , Castration Resistant Prostate Cancer , Amplitude Trial , Amplitude Study , Talapro 3 , Capitello 281 , Novel Therapy , Psma Targeted Therapy , Psma Treatment , Ar Pathway , Adverse Events , Drug Adverse Events , Safety Profile , Asco 2023 , Asco Annual Meeting ,